Title : REG-1, a regimen comprising RB-006, a Factor IXa antagonist, and its oligonucleotide active control agent RB-007 for the potential treatment of arterial thrombosis.

Pub. Date : 2009 Dec

PMID : 20072947






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 REG-1, a regimen comprising RB-006, a Factor IXa antagonist, and its oligonucleotide active control agent RB-007 for the potential treatment of arterial thrombosis. RB 006 zinc finger CCCH-type containing 12A Homo sapiens
2 REG-1, under development by Regado Biosciences Inc, is an intravenously administered anticoagulant system comprising the Factor IXa-inhibiting aptamer RB-006 and its complementary active control oligonucleotide, RB-007, for the potential treatment of arterial thrombosis. Oligonucleotides zinc finger CCCH-type containing 12A Homo sapiens